Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Sales, net	$ 49,977	$ 43,710
Cost of sales	43,755	38,722
Gross profit	6,222	4,988
Selling and administrative expenses	3,518	3,294
Operating income	2,704	1,694
Other income (expense), net:
Interest expense	(630)	(926)
Change in fair value of derivative liability	9	494
Unrealized loss on investment in iBio Stock	(23)
Impairment on investment in iBio Stock		(358)
Other (expense) income, net	(18)	101
Total other expense, net	(662)	(689)
Income before income taxes	2,042	1,005
Income tax expense, net	354	326
Net income	1,688	679
Expenses related to Convertible Debt - CD Financial, LLC:
Change in fair value of derivative liability		(494)
Interest expense, net of taxes		216
Amortization of prepaid financing costs, net of taxes		6
Accretion of Convertible debt		39
Diluted net income	$ 1,688	$ 446
Basic net income per common share (in dollars per share)	$ 0.06	$ 0.03
Diluted net income per common share (in dollars per share)	$ 0.06	$ 0.02
Weighted average common shares outstanding - basic (in shares)	28,930,495	21,135,174
Add: Equivalent shares outstanding - stock options (in shares)	656,055	951,399
Shares issuable upon conversion of Convertible Debt - CD Financial, LLC (in shares)		8,230,769
Weighted average common shares outstanding - diluted (in shares)	29,586,550	30,317,342